•
Sep 30, 2017

Viridian Therapeutics Q3 2017 Earnings Report

Total Revenue
$1.63M
Previous year: $889K
+83.5%
EPS
-$4.05
Previous year: -$2.56
+58.4%
Gross Profit
-$3.39M
Previous year: $290K
-1267.9%

Viridian Therapeutics

Viridian Therapeutics